In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020.
Click here for all the details: Communications
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...